Daniel Eduardo Groszmann

Title: **Daniel Eduardo Groszmann: Innovator in Drug Delivery Technologies**

Introduction

Daniel Eduardo Groszmann is a notable inventor based in Cambridge, MA, who holds an impressive portfolio of 27 patents. His work primarily focuses on the development of advanced drug delivery devices, aiming to enhance the efficiency and safety of medical treatments. His innovative contributions play a significant role in the progression of medical technology.

Latest Patents

Groszmann's latest patents include transformative designs in modular fluid path assemblies for drug delivery devices. These modular fluid path assemblies consist of conduit, coupling, and needle components fluidly connected to a container outlet. A key feature is the needle shield, which houses the needle tip, ensuring safety and sterility. The assemblies are designed to be sterilized, allowing a medicament to be pre-filled in the container with the integrity of a closed container seal maintained.

Another significant patent focuses on fluid path assemblies that introduce methods for establishing a fluid flow path within drug delivery devices. This innovation features a needle shield valve member that attaches to a reservoir containing a needle. The internal barrier protects the needle and stores the drug until device activation, thereby maintaining its integrity. Upon activation, the relative movement between the reservoir and the needle shield allows the needle to pierce the barrier, facilitating a controlled fluid path for medication delivery.

Career Highlights

Throughout his career, Groszmann has left an indelible mark in the field of biotechnology and medical devices. He has worked with prominent companies such as General Electric Company and Amgen Inc., where he has contributed his expertise in developing cutting-edge technologies. His roles have enabled the advancement of drug delivery mechanisms that prioritize patient safety and effective therapeutic outcomes.

Collaborations

Groszmann's journey has seen him collaborate with respected colleagues in the industry, including Scott Robert Gibson and Mehran Mojarrad. These collaborations have not only enhanced the scope of his work but also fostered an encouraging environment for innovation and problem-solving in the medical devices sector.

Conclusion

Daniel Eduardo Groszmann exemplifies the spirit of innovation in the medical technology landscape. With a strong foundation in drug delivery systems and a commitment to improving patient care through his inventions, he continues to be a driving force in the industry. His ongoing contributions pave the way for future advancements, underscoring the vital role of inventors in shaping the future of healthcare.